Terns Pharmaceuticals Inc. (NASDAQ:TERN) is among the hottest SMID-cap stocks so far in 2025. On November 17, Evan Seigerman of BMO Capital Markets raised his price target on the stock from $22 to $30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback